ResearcherDuke Medical CenterNo recent work listed

Jamie D. Weyandt

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-5602-5782; OpenAlex author ID A5042976615. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 2

Papers, trials and grants by year

2015: 2 papers

Papers 2

Activation Of Wild-Type Hras Suppresses The Earliest Stages Of Pancreatic Cancer. Co-author DOI 10.1016/j.redox.2015.09.014 ↗
Wild-Type Hras Suppresses the Earliest Stages of Tumorigenesis in a Genetically Engineered Mouse Model of Pancreatic Cancer. Co-author DOI 10.1371/journal.pone.0140253 ↗

Closest collaborators

The 2 strongest of 2 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Benjamin L. Lampson · 1 shared paper, 2015 · strength 0.06
- Paper Wild-Type Hras Suppresses the Earliest Stages of Tumorigenesis in a Genetically Engineered Mouse Model of Pancreatic Ca… DOI 10.1371/journal.pone.0140253 ↗
Christopher M Counter · 1 shared paper, 2015 · strength 0.06
- Paper Wild-Type Hras Suppresses the Earliest Stages of Tumorigenesis in a Genetically Engineered Mouse Model of Pancreatic Ca… DOI 10.1371/journal.pone.0140253 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.